PHASE I/II RANDOMIZED, PROSPECTIVE, DOUBLE-BLINDED, SHAM-CONTROLLED CROSS-OVER STUDY OF INTRAVITREAL AUTOLOGOUS BONE MARROW CD34+ STEM CELL THERAPY FOR RETINAL VEIN OCCLUSION